Overview
- Pennington, M. W. et al. (2015) Mar. Drugs, 13, 529.
- Alomone Labs ShK-235 blocks KV1.3 channels expressed in Xenopus oocytes.A. Representative time course of ShK-235 (#STS-380) inhibition of normalized KV1.3 current. Membrane potential was held at -80 mV, current was elicited by a 100 ms voltage ramp to +60 mV every 10 sec, and significantly inhibited by 0.1 nM (green) ShK-235. B. Superimposed traces of KV1.3 channel currents in the absence (control) and presence of 0.1 nM (green) ShK-235 (taken from the recording in A).
- Castaneda, O. et al. (1995) Toxicon, 33, 603.
- Kalman,K. et al. (1998) J. Biol. Chem., 273, 32697.
- Pennington, M. W. et al. (2015) Mar. Drugs, 13, 529.
- Chandy, K.G. et al. (2017) Curr. Opin. Chem. Biol., 38, 97.
- Pennington, M. W. et al. (2009) Mol. Pharmacol., 75, 762.
- Cahalan, M.D. et al. (2009) Immunol. Rev., 231, 59.
ShK-235 is a synthetic analog of ShK (Stichodactyla Toxin) (#STS-400), a native 35 amino acid peptidyl toxin originally isolated from the nematocyst of the sea anemone Stichodactyla helianthus1. Native ShK blocks the voltage-gated potassium (KV)1.3, KV1.1, KV1.4, and KV1.6 at subnanomolar concentrations2. Its synthetic analog, ShK-235, is a highly specific KV1.3 blocker with picomolar affinity and exhibited greater than 2250-fold selectivity for KV1.3 over KV1.1 and with very little block of other important KV subtypes (KV1.4 and KV1.6)3.
Kv channels play key roles in human physiology and pathology. The Kv1.3 channel in T lymphocytes is a validated therapeutic target for diverse autoimmune diseases4. This channel maintains the membrane potential of a sub-set of T lymphocytes known as effector memory (TEM) T cells, that mediate and play a major role in the pathogenesis of autoimmune diseases such as multiple sclerosis (MS), type 1 diabetes mellitus, rheumatoid arthritis (RA), and psoriasis5,6.
ShK-235 (#STS-380) is a highly pure, synthetic, and biologically active peptide toxin.